Literature DB >> 17279582

Thalidomide therapy in adult patients with myelodysplastic syndrome: a north central cancer treatment group phase II trial.

Pellegrino Musto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17279582     DOI: 10.1002/cncr.22516

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  1 in total

1.  Part 4: Myelodysplastic syndromes-Treatment of low-risk patients with the 5q deletion.

Authors:  Silvia Maria Meira Magalhães; Elvira Deolinda Rodrigues Pereira Velloso; Renata Buzzini; Wanderley Marques Bernardo
Journal:  Hematol Transfus Cell Ther       Date:  2018-07-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.